Avience Biomedicals Ltd PE Ratio

Avience Biomedicals PE Ratio

Image

Avience Biomedicals Ltd

NSE: Avience

PE

31.8

Last updated on: Jun 25, 2026

Key Highlights

  • The P/E Ratio of Avience Biomedicals Ltd is 31.8 as of 25 Jun 26 The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2024 to 0 on March 2025 . This represents a CAGR of 0.0% over 2 years The PE Ratio of Healthcare Industry has changed from 91.6 to 62.8 in 5 years. This represents a CAGR of -7.27% The PE Ratio of Automobile industry is 5.1. The PE Ratio of Finance industry is 24.1. The PE Ratio of Healthcare industry is 39.7. The PE Ratio of IT - Software industry is 18.2. The PE Ratio of Retail industry is 70.5. The PE Ratio of Textiles industry is 35.0 in 2026 .

Historical P/E Ratio of Avience Biomedicals Ltd

No data available

Company Fundamentals for Avience Biomedicals Ltd

Image

Avience Biomedicals Ltd

NSE: Avience

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Avience Biomedicals Ltd

1M

1Y

3Y

5Y

Monitoring Avience Biomedicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Jun 2026414.95

BlinkX Score for Avience Biomedicals Ltd

Asset Value vs Market Value of Avience Biomedicals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Avience Biomedicals Ltd Explained

227.6

Market cap

5

Earnings

45.0X

PE Ratio

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Avience Biomedicals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Avience Biomedicals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Avience Biomedicals Ltd

No data available

* All values are in %

About Avience Biomedicals Ltd

  • Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
  • Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of Incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
  • In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

Avience Biomedicals Ltd News Hub

NSE SME Avience Biomedicals debuts with a powerful heartbeat

The scrip was listed at Rs 395.20, a 90% premium to the initial public offer (IPO) price. The stock

Read more

25 Jun 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions